Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical…
– Four abstracts highlight Gene Circuit platforms that enhance the scope, precision, effectiveness, and controllability…
ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
PHILADELPHIA, Sept. 27, 2023 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq:…
PHILADELPHIA, Sept. 27, 2023 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq:…
Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational…
Certification Validates Company’s Commitment to Quality in all Areas, Helping to Advance Roadmap for Translational…
SAN FRANCISCO and BERLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) — T-knife Therapeutics, Inc., a clinical-stage…
SAN FRANCISCO and BERLIN, Sept. 27, 2023 (GLOBE NEWSWIRE) — T-knife Therapeutics, Inc., a clinical-stage…
PALO ALTO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
PALO ALTO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
GeneType and Gold Coast Hospital Simon Morriss – Genetic Technologies Ltd CEO and Michelle Ferrari…
GeneType and Gold Coast Hospital Simon Morriss – Genetic Technologies Ltd CEO and Michelle Ferrari…
Abstract titles to be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting…
Abstract titles to be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting…
Presentations to highlight new nonclinical data on product candidates, new technologies, innovations designed to shorten…
Presentations to highlight new nonclinical data on product candidates, new technologies, innovations designed to shorten…
Six abstracts, spanning Werewolf’s PREDATOR™ platform and INDUKINE™ pipeline, accepted for poster presentations at SITC…
Six abstracts, spanning Werewolf’s PREDATOR™ platform and INDUKINE™ pipeline, accepted for poster presentations at SITC…